Rabinder Prinjha is VP Head of Epinova Epigenetics. An outstanding scientist who is a world leading figure in the emerging field of epigenetics drug discovery, and is also a very active leader at the industry-academic interface helping to advance medical science. His high impact translational science and the molecules his group has discovered have made him the partner of choice for two leading academic laboratories. His work is widely recognised as a key contribution to the field and in addition to this he is very active in supporting science and is leading the EU Innovative Medicines Initiative Immunology Strategic Governance Group.
Fellow
Back to directory listingDr Rabinder Prinjha FMedSci
Job Title
VP Head Epinova Epigenetics
Institution
GlaxoSmithKline (GSK)
Year elected
2017
Interests
Section committee elected byPrimary care, health services research, health informatics, health improvement, social sciences, humanities, law, policy, communication or leadership as applied to health or biomedical science